Product Information
OLANZAPINE ODT 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3035 per EA under NDC 33342008307. Its NADAC has been published 569 times since Nov 11, 2015.
FDA first approved this application on Feb 20, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342008307
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA203044FDA Approved
2/20/2015
TE Code
AB
On Market Since
2/27/2015
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE ODT 5 MG TABLET has been published 569 times since Nov 11, 2015, and over the history we have for it it has declined 81.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3035 per EA |
|---|---|
| All-time high | $1.8733 (Feb 10, 2016) |
| All-time low | $0.2692 (Jan 22, 2025) |
| 52-week high | $0.3254 |
| 52-week low | $0.2890 |
| Median price | $0.5366 |
| Average price | $0.6944 |
| Largest weekly change | +74.4% (Sep 19, 2018) |
| Weeks tracked | 569 |
| Tracking since | Nov 11, 2015 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olanzapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLANZAPINE ODT 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE ODT 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.3035 per EA (NDC 33342008307), effective Sep 30, 2026.
How has the price of OLANZAPINE ODT 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OLANZAPINE ODT 5 MG TABLET has declined 81.0%. It has been tracked across 569 weekly CMS publications since Nov 11, 2015.
What are the highest and lowest recorded NADAC prices for OLANZAPINE ODT 5 MG TABLET?
Since Nov 11, 2015, the NADAC for OLANZAPINE ODT 5 MG TABLET has ranged from a low of $0.2692 (Jan 22, 2025) to a high of $1.8733 (Feb 10, 2016), with a median of $0.5366 per EA.
Are there cheaper alternatives to OLANZAPINE ODT 5 MG TABLET?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLANZAPINE 5 MG TABLET, is $0.0867 per EA — about 71% below OLANZAPINE ODT 5 MG TABLET.
Who manufactures OLANZAPINE ODT 5 MG TABLET?
OLANZAPINE ODT 5 MG TABLET (NDC 33342008307) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.